Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Rhythm disorders and infarction].

F W Amann1

  • 1Departement für Innere Medizin, Universitätsspital, Zürich.

Therapeutische Umschau. Revue Therapeutique
|August 1, 1991
PubMed
Summary
This summary is machine-generated.

Ventricular arrhythmias, including ventricular tachycardia and fibrillation, are a leading cause of cardiac death after myocardial infarction. Risk stratification and targeted therapies improve outcomes for affected patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LEOPARD syndrome: cardiac imaging findings.

AJR. American journal of roentgenology·2005
Same author

[Coronary stents].

Therapeutische Umschau. Revue therapeutique·2003
Same author

[Medicamentous management of acute coronary syndrome without ST segment elevation].

Therapeutische Umschau. Revue therapeutique·2002
Same author

Post-prandial lipaemia and endothelial function among healthy men.

Swiss medical weekly·2001
Same author

Isradipine improves endothelium-dependent vasodilation in normotensive coronary artery disease patients with hypercholesterolemia.

Journal of hypertension·2001
Same author

Acceleration of confirmed coronary artery disease among HIV-infected patients on potent antiretroviral therapy.

AIDS (London, England)·2000
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

Area of Science:

  • Cardiology
  • Electrophysiology
  • Internal Medicine

Context:

  • Ventricular arrhythmias are a significant complication following myocardial infarction (MI).
  • These arrhythmias are a primary cause of sudden cardiac death in both acute and late stages post-MI.
  • Risk factors include impaired left ventricular function and electrical instability.

Purpose:

  • To summarize the causes, risk factors, and management strategies for ventricular arrhythmias after myocardial infarction.
  • To highlight the prognostic implications and therapeutic options for patients experiencing sustained ventricular tachycardia and fibrillation.

Summary:

  • Ventricular arrhythmias, such as ventricular tachycardia (VT) and ventricular fibrillation (VF), are common and life-threatening complications of myocardial infarction.

Related Experiment Videos

  • Key risk factors for sudden cardiac death include reduced left ventricular function, electrical instability (e.g., complex ventricular premature beats, late potentials), bundle branch block, and ventricular aneurysm.
  • While beta-blockers aid secondary prevention, most antiarrhythmic drugs are not recommended for asymptomatic patients due to proarrhythmic risks; amiodarone is an exception.
  • Prognosis for sustained VT/VF is poor, but outcomes can improve with tailored antiarrhythmic therapy, surgical interventions, or cardioverter-defibrillator implantation.

    • Impact:

    • Identifies critical risk factors for sudden cardiac death post-MI, aiding in patient stratification.
    • Clarifies the role and limitations of antiarrhythmic drug therapy, emphasizing the risks of proarrhythmia.
    • Underscores the importance of advanced therapies like cardioverter-defibrillators for improving survival in high-risk patients.